Dermatomyositis Multidisciplinarity Antisynthétase Myositis and muscle disease Deep immune profiling Bioelectrical impedance analysis Anti-interleukin-6 Active Aged Immune checkpoint inhibitors Fabry disease Middle Aged Auto‐antibodies IMNM Animals Autoimmunity Male COVID-19 Aldosterone Inborn errors of metabolism Anti‐mitochondrial antibodies AAV antibody Interstitial lung disease Inflammation Anti-drug antibodies Inclusion body myositis Skeletal muscle Biomarker Adolescence Mass cytometry AAV vector Myositis Adeno-associated virus vector Adult Myopathy Dependovirus/genetics/immunology Interferon Biomarqueurs Polymyositis Antisynthetase syndrome Lysosomal storage diseases Antisynthetase Amyotrophy B cell homeostasis Amyotrophic lateral sclerosis Female AAV humoral immunity Autoantibody Humans Prognosis Anti-MDA5 autoantibodies Anti-synthetase syndrome Arthritis Adjudication IBM Auto-antibodies Myocarditis Anticorps anti-agalsidase Auto-immunité Autoantibodies Systems biology Immunotherapy Autoimmune diseases Anti-IgE IgG Anémie hémolytique Analyses multidimensionnelles Biomarkers Adverse drug reactions Acid-alpha-glucosidase Adeno-associated virus Data integration Idiopathic inflammatory myopathies DM AAV vectors Assisted communication devices Inflammatory myopathy Outcome measures AAV Abnormal movement Biopsy Agalsidase Cytokines Aldostérone Cardio-oncology Anti-Mi2 Anti-agalsidase antibodies Gene therapy B-lymphocyte Antibody responses Muscle Case reports Cancer Pharmacology Machine learning Adeno-associated vector Antiphospholipid syndrome Sphingosine-1-phosphate Acute Kidney Injury/epidemiology/etiology Anticorps spécifique des myosites Antibodies